|Chemical and physical data|
|Molar mass||407.451 g/mol g·mol−1|
|3D model (JSmol)|
Velneperit (S-2367) is a drug developed by Shionogi, which acts as a potent and selective antagonist for the Neuropeptide Y receptor Y5. It has anorectic effects and was developed as a possible treatment for obesity, but was discontinued from further development after disappointing results in Phase II clinical trials. However it was still considered a successful proof of concept of the potential of Y5 receptor antagonists as possible anti-obesity agents in future.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|